This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q92245139
rdf:type
wikibase:Item
schema:description
artículo científico publicado en 2019 tudományos cikk 2019 nî lūn-bûn artikull shkencor scienca artikolo wetenschappelijk artikel naučni članak scientific article published on 4 September 2019 2019年学术文章 научни чланак artigo científico 2019年學術文章 2019年学术文章 scientific article published on 04 September 2019 article científic 2019年学术文章 επιστημονικό άρθρο article scientific научни чланак artikulong pang-agham 2019年の論文 2019年學術文章 articol științific 2019年学术文章 teaduslik artikkel bài báo khoa học scientific article published on 4 September 2019 vitenskapelig artikkel 2019年學術文章 научна статия ৪ সেপ্টেম্বর ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ სამეცნიერო სტატია مقالة علمية نشرت في 4 سبتمبر 2019 מאמר מדעי wissenschaftlicher Artikel 2019年学术文章 บทความทางวิทยาศาสตร์ vitskapeleg artikkel vedecký článok artikel ilmiah bilimsel makale 2019년 논문 videnskabelig artikel udgivet 4. september 2019 vetenskaplig artikel artigo científico vědecký článek artículu científicu articolo scientifico 2019年學術文章 article scientifique мақолаи илмӣ 2019年學術文章 2019年学术文章 tieteellinen artikkeli научная статья artigo científico наукова стаття, опублікована у вересні 2019 artykuł naukowy
p:P577
wds:Q92245139-2E894B7A-A2C7-4442-ACD3-E2D89D935994
wdt:P577
2019-09-04T00:00:00Z
p:P2860
wds:Q92245139-238DBF0B-3019-4FB6-8902-23B70EE82E9C wds:Q92245139-25BD5F39-9CA0-4C4F-BD1D-782F03BEE7B6 wds:Q92245139-E05DDD56-BE51-4DC1-82CB-85EC85B88FA4 wds:Q92245139-EE281438-5762-479D-9B3A-B20FC4ADDC66 wds:Q92245139-E0E01F70-E6FC-4A45-832A-CBA9C4E53A30 wds:Q92245139-FD928E26-7AA1-489A-A4A1-47281EBDF870 wds:Q92245139-7EF634C9-8F3D-4E6E-8079-C93E1FD2D33C wds:Q92245139-7E51373E-CFE1-4E8A-9FA3-D59FD1411098 wds:Q92245139-8B4A8A40-5B40-4D25-B977-A0554BCD2090 wds:Q92245139-B882BF48-D053-4C70-BFB0-9F1BB272294C wds:Q92245139-01EC5BC6-3612-48F3-B62A-CC6D2573B1B3 wds:Q92245139-17257145-1577-42F3-A539-88BD320D44D3 wds:Q92245139-502CFB6A-2618-4E18-BBB1-351512F6BFFF wds:Q92245139-5D2AF2E4-7D54-4946-9550-212FA898092E wds:Q92245139-7A1BF624-0971-4FEB-BD73-C152CE127DA2 wds:Q92245139-73D562AA-34E7-44DE-A96E-74E76557FC16 wds:Q92245139-201EC1DB-A2C2-4A75-8507-2C500CDF71E5 wds:Q92245139-2430901F-4579-4405-8F9A-6BF217C18085
wdt:P2860
wd:Q27659474 wd:Q35049420 wd:Q42660454 wd:Q34521260 wd:Q29616732 wd:Q34202686 wd:Q77345239 wd:Q48216923 wd:Q45976197 wd:Q33427510 wd:Q36646617 wd:Q47139831 wd:Q82667897 wd:Q64981692 wd:Q38351470 wd:Q42947696 wd:Q34465347 wd:Q34496360
p:P2093
wds:Q92245139-DF20EA7C-D665-488B-BF36-A13A705CCB91 wds:Q92245139-BB798AA6-722B-419A-AB8F-CA81E13B402C wds:Q92245139-A1026881-2FE0-403B-B0A0-7604CF2B907E wds:Q92245139-5983E612-E1A8-4817-B89D-0F0C84529A1D
wdt:P2093
Diane R Mould Douglas V Faller Xiaofei Zhou Farhad Sedarati
rdfs:label
Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies
skos:prefLabel
Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies
schema:name
Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies
p:P50
wds:Q92245139-13C58755-8D36-4C22-87D6-58715C87267D wds:Q92245139-A53D6E81-3111-4AE9-8E3D-FEB5303049B0
wdt:P50
wd:Q88953164 wd:Q92198949
p:P1476
wds:Q92245139-118C20BA-36A5-4657-B6D4-7409F75C7F87
wdt:P1476
Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies
p:P304
wds:Q92245139-C8E8D964-CC8F-4298-9FB4-D7430BFB06EE
wdt:P304
2568-2579
p:P31
wds:Q92245139-86DCCBC2-C421-4B33-B99E-B8BAB19C4DCF
wdt:P31
wd:Q13442814
p:P698
wds:Q92245139-20E3FC66-B02F-4EFD-AF16-E243850F8145
wdtn:P698
n11:31355467
wdt:P698
31355467
p:P1433
wds:Q92245139-59872210-423E-46BF-B3BF-A498E6EFADD9
wdt:P1433
wd:Q176044
p:P433
wds:Q92245139-3C05D6B0-3BA1-4C38-9333-500B63CD71F0
p:P478
wds:Q92245139-5AA7AFCF-D29B-44F3-A7BC-D7937608CE70
wdt:P433
11
wdt:P478
85
p:P356
wds:Q92245139-B8D5E111-5FDE-4977-A353-5AF06B4AEF53
wdtn:P356
n8:BCP.14078
wdt:P356
10.1111/BCP.14078
p:P4510
wds:Q92245139-4E5408F6-5B10-44AD-908E-ABDA14CA9DFA
wdt:P4510
wd:Q326489
p:P932
wds:Q92245139-63CE8578-DE13-4CDD-B667-1F5F02DC3255
wdt:P932
6848912